Razafindranaly
Papers
1
Total Citations
4
H-Index
1
About
Dr. Razafindranaly is a leading French otolaryngologist and head and neck surgeon whose work has advanced minimally invasive surgical approaches for laryngopharyngeal cancers. His primary research focuses on transoral robotic surgery (TORS) for supraglottic squamous cell carcinoma, with a particular emphasis on organ preservation and functional outcomes. As a key contributor to the GETTEC cooperative group, Dr. Razafindranaly has helped establish evidence for TORS as a safe, effective alternative to combined chemoradiotherapy, reducing treatment toxicity while maintaining oncologic control. His 2015 study on clinical outcomes of TORS for supraglottic carcinoma, cited 4 times, demonstrated the procedure's efficiency and safety, highlighting its role in preserving swallowing and voice function. This work has influenced surgical practice in France and beyond, positioning Dr. Razafindranaly as a specialist in the intersection of robotic surgery and head and neck oncology. His contributions continue to shape the paradigm toward less invasive, function-sparing treatments for patients with laryngopharyngeal malignancies.
Research Focus
Key Achievements
Top Papers
- 1